Hormone Patches or Creams for Menopause Symptoms May Have Lower Blood Pressure Risk Than Pills

June 5, 2023by Lauran Neergaard, Associated Press
Hormone Patches or Creams for Menopause Symptoms May Have Lower Blood Pressure Risk Than Pills
This Tuesday, Oct. 2, 2012 photo shows a low-dose estrogen skin patch. (AP Photo/File)

WASHINGTON (AP) — Women often use hormone therapy to relieve hot flashes and other menopause symptoms — and new research suggests patches or creams may be safer for their blood pressure than pills.

As women’s bodies produce lower levels of reproductive hormones during menopause their risk for heart disease rises. High blood pressure further increases that risk — but it’s not clear whether there’s a link with hormone therapy for menopause symptoms.

Canadian researchers wondered if the way hormones are absorbed — orally, vaginally or through the skin — could play a role.

The University of Calgary team examined health records of more than 112,000 women ages 45 and older who filled prescriptions for at least six months’ worth of estrogen-only hormone treatment between 2008 and 2019. They tracked which women went on to develop high blood pressure at least a year after starting treatment.

While the differences weren’t huge, women who took estrogen pills had a 14% higher risk of developing hypertension compared to those using skin patches or creams, the researchers reported Monday. Oral estrogen carried a 19% greater risk than vaginal versions.

The findings were published in the journal Hypertension.

Hormone therapy has a mix of risks and benefits that mean it’s not for everyone. Today it’s prescribed not to prevent disease but to relieve menopause-related symptoms — generally using the lowest possible dose for the shortest time. Most commonly used are combination pills of estrogen and another hormone, progestin. (Estrogen-only pills typically are prescribed to women without a uterus.)

Different versions of hormone therapy may work better for different menopause symptoms, something the study didn’t address.

But it adds important clues to understanding the complex relationship between hormone therapy and blood pressure, said Dr. Garima Sharma, a women’s heart specialist with Virginia’s Inova Health System and the American Heart Association.

Sharma would like to see a more rigorous trial that compares different hormone versions. But she pointed to a possible biological explanation: Maybe oral estrogen affects enzymes linked to blood pressure as it’s being processed, while skin and vaginal versions have much more limited activity in the body.

Still, “these findings are very clinically relevant,” Sharma said in an an email, and suggest it’s especially important to monitor blood pressure in women who use oral hormone therapy.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

A+
a-

In The News

Health

Voting

Health

March 27, 2024
by Dan McCue
One-Time Treatment Could Revitalize Immune Systems in the Elderly

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

March 27, 2024
by Dan McCue
Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

Five Takeaways From the Abortion Pill Case Before US Supreme Court

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

March 26, 2024
by Tom Ramstack
Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

March 26, 2024
by Dan McCue
Consumers Warned to Avoid Certain Topical Pain Relief Products 

WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed... Read More

WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed for topical use before, during or after certain cosmetic procedures. The warning came after the agency issued warning letters to six companies for marketing these products... Read More

News From The Well
scroll top